Texas A&M Football

Cover Story: LSU win offers hope as A&M enters an important offseason

A top-five win to close a frustrating campaign sends Jimbo Fisher and the Aggies into a crucial offseason with legitimate reasons for hope. With plenty of top-tier talent already on campus, what happens in Aggieland over the next couple of months is extremely important.
By Billy Liucci
December 1, 2022
15k Views
Discuss
Story Poster
Photo by Maria Lysaker-USA TODAY Sports

"Let me tell you something, my friend. Hope is a dangerous thing. Hope can drive a man insane."

You all know the movie. If you don't, there's your homework assignment for this week. Your schedule should have an opening this Saturday, as our Aggies won't be taking the field again until next September.

Until then, there's hope. Well, at least now there is.

To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
D.J. Durkin John Chavis Darrell Dickey Offensive Line Hugh Freeze Josh Heupel Cover Story Lane Kiffin Scott Woodward Ed Orgeron Jimbo Fisher Joe Burrow
Show All
Jayden Daniels Brian Kelly Shane Beamer NIL Transfer Portal Texas A&M vs. LSU Antonio Johnson Jaylon Jones Max Wright Demani Richardson Ainias Smith Devon Achane McKinnley Jackson Amari Daniels Max Johnson Layden Robinson Moose Muhammad III Edgerrin Cooper Donovan Green Conner Weigman Noah Thomas Evan Stewart Football Football Recruiting Texas A&M LSU South Carolina Tennessee Auburn Alabama Ole Miss 2022
More Football
See All →
Cover Story: Next task is taking A&M's top-five show on the road
By Billy Liucci
Le'Veon Moss to miss 'significant period of time' with ankle injury
By Richard Zane
Press Conference: Elko & Co. head to Fayetteville to face Arkansas
By TexAgs
Live Press Conference Notes: Elko previews road trip to Arkansas
By Kay Naegeli
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.